SENP7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.002800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.349800E-02
Normal-vs-Stage2
1.954210E-01
Normal-vs-Stage3
1.397390E-01
Normal-vs-Stage4
1.726760E-01
Stage1-vs-Stage2
3.062200E-01
Stage1-vs-Stage3
5.008200E-02
Stage1-vs-Stage4
8.846400E-01
Stage2-vs-Stage3
1.861560E-01
Stage2-vs-Stage4
3.106400E-01
Stage3-vs-Stage4
8.798000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.014400E-01
Normal-vs-AfricanAmerican
1.878960E-01
Normal-vs-Asian
1.753000E-01
Caucasian-vs-AfricanAmerican
7.131400E-01
Caucasian-vs-Asian
3.741200E-01
AfricanAmerican-vs-Asian
7.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.848230E-01
Normal-vs-Female
3.239900E-03
Male-vs-Female
5.312000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.546800E-01
Normal-vs-Age(41-60Yrs)
2.314000E-01
Normal-vs-Age(61-80Yrs)
1.894560E-01
Normal-vs-Age(81-100Yrs)
1.804620E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.977000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.733800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.613200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.352000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.311440E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.210200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.086800E-01
Normal-vs-Daily Drinker
1.646440E-01
Normal-vs-Weekly Drinker
1.721430E-01
Normal-vs-Occasional Drinker
5.554000E-02
Normal-vs-Social Drinker
1.397750E-02
Non Drinker-vs-Daily Drinker
1.047980E-01
Non Drinker-vs-Weekly Drinker
2.471000E-01
Non Drinker-vs-Occasional Drinker
5.730800E-01
Non Drinker-vs-Social Drinker
9.705200E-01
Daily Drinker-vs-Weekly Drinker
8.409000E-01
Daily Drinker-vs-Occasional Drinker
1.302560E-01
Daily Drinker-vs-Social Drinker
1.982380E-01
Weekly Drinker-vs-Occasional Drinker
1.963580E-01
Weekly Drinker-vs-Social Drinker
3.563000E-01
Occasional Drinker-vs-Social Drinker
6.539600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.318760E-01
Normal-vs-Grade 2
4.983100E-03
Normal-vs-Grade 3
3.144000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.354800E-01
Grade 1-vs-Grade 3
5.815600E-01
Grade 1-vs-Grade 4
1.318760E-01
Grade 2-vs-Grade 3
6.253400E-01
Grade 2-vs-Grade 4
4.983100E-03
Grade 3-vs-Grade 4
3.144000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.815980E-01
Normal-vs-NonDiabetic
1.972770E-01
Diabetic-vs-NonDiabetic
4.199400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.516820E-01
Normal-vs-NoPancreatitis
1.954760E-01
Pancreatitis-vs-NoPancreatitis
1.161390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.883300E-03
Normal-vs-N1
1.961450E-01
N0-vs-N1
5.967800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.893040E-01
Normal-vs-TP53-NonMutant
2.416800E-01
TP53-Mutant-vs-TP53-NonMutant
9.354000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
